SOLID TUMOR AND LYMPHOMA

Clinical trials for SOLID TUMOR AND LYMPHOMA explained in plain language.

Never miss a new study

Get alerted when new SOLID TUMOR AND LYMPHOMA trials appear

Sign up with your email to follow new studies for SOLID TUMOR AND LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New drug HX111 targets advanced cancers in early trial

Disease control Not yet recruiting

This study tests a new drug called HX111 in people with advanced solid tumors or lymphoma that has not responded to other treatments. The trial has two parts: first, finding the safest dose, and then checking how well it works. About 70 adults aged 18 to 70 with a life expectancy…

Matched conditions: SOLID TUMOR AND LYMPHOMA

Phase: PHASE1, PHASE2 • Sponsor: Hanx Biopharmaceuticals (Wuhan) Co., Ltd. • Aim: Disease control

Last updated May 04, 2026 16:24 UTC

SOLID TUMOR AND LYMPHOMA

Get alerted when new SOLID TUMOR AND LYMPHOMA trials appear

New drug HX111 targets advanced cancers in early trial